More on SMNR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings

Upcoming Events

- Earnings (11/18/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(OP:SMNR)
Delayed: 0.83 -0.02 (2.35%)
Prev. Close $0.85  
Open$0.65 
52 Wk High$ 
52 Wk Low$ 
Day High$0.84 
Day Low$0.65 
P/E N/A  
EPS$ 
Volume5,099 

Friends, Peers and Foes (?): SCLX, SCLXW, SMNRW DECA (more...)

Jul 7, 2026 10:49 AM Form 424B3 Semnur Pharmaceuticals,
Jul 7, 2026 10:41 AM Form 8-K Semnur Pharmaceuticals, For: Jul 03
Jul 7, 2026 06:00 AM Semnur signs $100M binding term sheet with Kazakhstan investor
Jul 7, 2026 06:00 AM Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat
Jul 1, 2026 06:07 AM Form 424B3 Semnur Pharmaceuticals,
Jun 26, 2026 04:24 PM Form SCHEDULE 13D/A Semnur Pharmaceuticals, Filed by: Scilex Holding Co
Jun 26, 2026 04:20 PM Form 4 Semnur Pharmaceuticals, For: Jun 15 Filed by: Scilex Holding Co
Jun 25, 2026 05:04 PM Form 8-K Semnur Pharmaceuticals, For: Jun 25
Jun 15, 2026 05:02 PM Form 424B3 Semnur Pharmaceuticals,
Jun 15, 2026 07:00 AM Form 424B3 Semnur Pharmaceuticals,
View All Articles

Entities mentioned with SMNR

View All Entities